Research progress of diagnosis and treatment of inflammatory bowel disease with Epstein-Barr virus infection
10.3760/cma.j.cn101480-20190410-00041
- VernacularTitle:炎症性肠病合并EB病毒感染的诊治进展
- Author:
Dandan ZHAO
1
;
Fengrong YIN
1
;
Jinbo GUO
1
;
Xiaolan ZHANG
1
Author Information
1. 河北医科大学第二医院消化内科 河北省消化病重点实验室 河北省消化病研究所，石家庄 050000
- Publication Type:Journal Article
- Keywords:
Inflammatory bowel disease;
Epstein-Barr virus;
Risk factors;
Diagnosis;
Therapeutic strategies
- From:
Chinese Journal of Inflammatory Bowel Diseases
2020;04(4):292-297
- CountryChina
- Language:Chinese
-
Abstract:
Inflammatory bowel disease (IBD) is a recurrent chronic non-specific intestinal inflammatory disease. Because of the poor nutritional status and immune dysfunction caused by IBD, and the therapeutic application of glucocorticoid and immunosuppressive agents in some patients, the IBD patients are at high risk of opportunistic infections. Epstein-Barr virus (EBV) is a kind of opportunistic causative virus which is common in IBD patients. EBV infection can cause the rapid disease progresses, worsen the effect of conventional medicine treatment, and induce the EBV-associated lymphoproliferative disorders. This article discusses the epidemiology, risk factors, clinical characteristics and the therapeutic strategies of IBD patients with EBV infection.
